Pentoz 20 And 40 20mg. 40mg Delayed release FC tablet
PDF Leaflet Revision Date: 18 January 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of gastro-oesophageal reflux disease and ulcers.
Dosage (summary)
PENTOZ 20: 20 mg once daily; PENTOZ 40: 40 mg once daily for 4-8 weeks.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Atazanavir
- Methotrexate
- CYP2C19 inhibitors
Contraindications
- Hypersensitivity to pantoprazole
- Severe liver impairment
- Children
Common side effects
- Headache
- Dizziness
- Gastrointestinal complaints
Counselling Points
- Take in the morning before breakfast
- Do not crush or chew tablets
- Monitor for signs of hypomagnesaemia
Serious warnings
- Risk of hypomagnesaemia
- Clostridium difficile-associated diarrhoea
- Severe cutaneous adverse reactions
Important Disclaimer
The Pentoz 20 And 40 20mg. 40mg Delayed release FC tablet professional information leaflet below is the property of Dr Reddy’S Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
